Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:200-206
Published online before print July 5, 2005, doi: 10.1161/CIRCULATIONAHA.104.506345
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
112/2/200    most recent
CIRCULATIONAHA.104.506345v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Van Kien, P. K.
Right arrow Articles by Jeunemaitre, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Van Kien, P. K.
Right arrow Articles by Jeunemaitre, X.
Related Collections
Right arrow Clinical genetics
Right arrow Peripheral vascular disease
Right arrow CT and MRI
Right arrow CV surgery: aortic and vascular disease
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Genetics of cardiovascular disease
Right arrow Other Vascular biology

(Circulation. 2005;112:200-206.)
© 2005 American Heart Association, Inc.


Genetics

Mapping of Familial Thoracic Aortic Aneurysm/Dissection With Patent Ductus Arteriosus to 16p12.2–p13.13

Philippe Khau Van Kien, MD*; Flavie Mathieu, PhD*; Limin Zhu, MD; Alain Lalande, PhD; Christine Betard, PhD; Mark Lathrop, MD, PhD; François Brunotte, MD, PhD; Jean-Eric Wolf, MD, PhD; Xavier Jeunemaitre, MD, PhD

From INSERM U36 and Collège de France; Département de Génétique, Hôpital Européen Georges Pompidou, Assistance Publique, Hôpitaux de Paris; and Faculté de Médecine Paris-Descartes, Paris (P.K.V.K., F.M., L.Z., K.J.); Laboratoire de Pharmacologie et de Physiopathologie Cardiovasculaire Expérimentale, CHU Dijon, and Université de Bourgogne, Dijon (P.K.V.K., F.B., J.-E.W.); Service de Cardiologie II (P.K.V.K., J.-E.W.) and Centre d’IRM (A.L., F.B.), CHU Dijon, Dijon; and Centre National de Génotypage, Evry (C.B., M.L.), France.

Correspondence to Xavier Jeunemaitre, MD, PhD, Collège de France, INSERM U36, 11, Place Marcelin Berthelot, 75005 Paris, France. E-mail xavier.jeunemaitre{at}college-de-france.fr or xavier.jeunemaitre@egp.aphp.fr

Received September 12, 2004; revision received March 8, 2005; accepted March 30, 2005.

Background— Three loci have been shown to be responsible for nonsyndromic familial thoracic aortic aneurysms (TAAs) and aortic dissections (ADs). We recently described a large family in which TAA/AD associates with patent ductus arteriosus (PDA) and provided genetic arguments for a unique pathophysiological entity.

Methods and Results— Genome-wide scan was performed in 40 subjects belonging to 3 generations in this large pedigree. Using the 7 TAA/AD cases as affected, we observed positive 2-point LOD scores on adjacent markers at chromosome 16p, with a maximum LOD score value of 2.73 at {theta}=0, a value that increased to 3.56 when 5 PDA cases were included. Multipoint linkage analysis yielded a maximum LOD score of 4.14 in the vicinity of marker D16S3103. Fine mapping allowed the observation of recombinant haplotypes that delimited a critical 20-cM interval at 16p12.2-p13.13. Automatic determination of aortic compliance with cine MRI showed that all subjects bearing the disease haplotype, even asymptomatic, displayed a very low level of aortic compliance and distensibility. Aortic stiffness was strongly associated with disease haplotype with a marked effect of age, indicating subclinical and early manifestation of the disease.

Conclusions— Genetic analysis of this family identified a unique locus responsible for both TAA/AD and PDA at chromosome 16p12.2-p13.13 with aortic stiffness as an early hallmark of the disease. TAA/AD with PDA is a new monogenic entity among the genetically heterogeneous group of TAA/AD disease.


Key Words: aneurysm • aorta • ductus arteriosus • genetics • mapping




This article has been cited by other articles:


Home page
CirculationHome page
G. D. Pearson, R. Devereux, B. Loeys, C. Maslen, D. Milewicz, R. Pyeritz, F. Ramirez, D. Rifkin, L. Sakai, L. Svensson, et al.
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on Research in Marfan Syndrome and Related Disorders
Circulation, August 12, 2008; 118(7): 785 - 791.
[Full Text] [PDF]


Home page
CirculationHome page
H. Kuivaniemi, C. D. Platsoucas, and M. D. Tilson III
Aortic Aneurysms: An Immune Disease With a Strong Genetic Component
Circulation, January 15, 2008; 117(2): 242 - 252.
[Full Text] [PDF]


Home page
Hum Mol GenetHome page
H. Pannu, V. Tran-Fadulu, C. L. Papke, S. Scherer, Y. Liu, C. Presley, D. Guo, A. L. Estrera, H. J. Safi, A. R. Brasier, et al.
MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II
Hum. Mol. Genet., October 15, 2007; 16(20): 2453 - 2462.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
L. Kota, M. Osborne-Pellegrin, H. Schulz, J. Behmoaras, M. Coutard, M. Gong, and N. Hubner
Quantitative genetic basis of arterial phenotypes in the Brown Norway rat
Physiol Genomics, June 19, 2007; 30(1): 17 - 25.
[Abstract] [Full Text] [PDF]